Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon

Investing.com Gold reports: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon. Full body text was unavailable at ingest time, so this brief is based on headline context.